全文获取类型
收费全文 | 7688篇 |
免费 | 532篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 273篇 |
妇产科学 | 131篇 |
基础医学 | 1087篇 |
口腔科学 | 160篇 |
临床医学 | 667篇 |
内科学 | 1530篇 |
皮肤病学 | 135篇 |
神经病学 | 1080篇 |
特种医学 | 347篇 |
外科学 | 748篇 |
综合类 | 74篇 |
一般理论 | 3篇 |
预防医学 | 745篇 |
眼科学 | 305篇 |
药学 | 467篇 |
中国医学 | 7篇 |
肿瘤学 | 458篇 |
出版年
2023年 | 80篇 |
2022年 | 133篇 |
2021年 | 274篇 |
2020年 | 185篇 |
2019年 | 220篇 |
2018年 | 262篇 |
2017年 | 180篇 |
2016年 | 230篇 |
2015年 | 247篇 |
2014年 | 324篇 |
2013年 | 410篇 |
2012年 | 604篇 |
2011年 | 573篇 |
2010年 | 310篇 |
2009年 | 241篇 |
2008年 | 409篇 |
2007年 | 430篇 |
2006年 | 358篇 |
2005年 | 381篇 |
2004年 | 345篇 |
2003年 | 256篇 |
2002年 | 238篇 |
2001年 | 111篇 |
2000年 | 113篇 |
1999年 | 106篇 |
1998年 | 49篇 |
1997年 | 57篇 |
1996年 | 29篇 |
1995年 | 34篇 |
1994年 | 34篇 |
1993年 | 25篇 |
1992年 | 64篇 |
1991年 | 62篇 |
1990年 | 61篇 |
1989年 | 65篇 |
1988年 | 58篇 |
1987年 | 55篇 |
1986年 | 51篇 |
1985年 | 53篇 |
1984年 | 41篇 |
1983年 | 31篇 |
1982年 | 34篇 |
1979年 | 43篇 |
1978年 | 28篇 |
1977年 | 28篇 |
1975年 | 24篇 |
1974年 | 27篇 |
1973年 | 32篇 |
1970年 | 23篇 |
1968年 | 26篇 |
排序方式: 共有8260条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Sabrina Ronco 《Nursing for Women's Health》2021,25(3):207-211
A review of the literature was performed to explore the association between prenatal education and rates of primary cesarean birth for women at low risk for cesarean birth. Most women who are nulliparous with a singleton fetus of term gestational age and in the vertex position are considered to be at low risk and favorable for a vaginal birth, yet the cesarean birth rate for women at low risk was 25.6% in 2019. It has been suggested that the rise in the cesarean birth rate among low-risk women may not be due to medical indications but, rather, to nonmedical factors, such as a provider’s or woman’s preference or lack of prenatal education. Evidence from this literature review supports the premise that prenatal education classes should be routinely incorporated into maternity care in an effort to reduce cesarean birth rates for the low-risk population. 相似文献
5.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
6.
7.
J.L. Bernat A.M. D'Alessandro F.K. Port T.P. Bleck S.O. Heard J. Medina S.H. Rosenbaum M.A. DeVita R.S. Gaston R.M. Merion M.L. Barr W.H. Marks H. Nathan K. O'Connor D.L. Rudow A.B. Leichtman P. Schwab N.L. Ascher R.A. Metzger V. Mc Bride W. Graham D. Wagner J. Warren F.L. Delmonico 《American journal of transplantation》2006,6(2):281-291
A national conference on organ donation after cardiac death (DCD) was convened to expand the practice of DCD in the continuum of quality end-of-life care. This national conference affirmed the ethical propriety of DCD as not violating the dead donor rule. Further, by new developments not previously reported, the conference resolved controversy regarding the period of circulatory cessation that determines death and allows administration of pre-recovery pharmacologic agents, it established conditions of DCD eligibility, it presented current data regarding the successful transplantation of organs from DCD, it proposed a new framework of data reporting regarding ischemic events, it made specific recommendations to agencies and organizations to remove barriers to DCD, it brought guidance regarding organ allocation and the process of informed consent and it set an action plan to address media issues. When a consensual decision is made to withdraw life support by the attending physician and patient or by the attending physician and a family member or surrogate (particularly in an intensive care unit), a routine opportunity for DCD should be available to honor the deceased donor's wishes in every donor service area (DSA) of the United States. 相似文献
8.
Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder 总被引:1,自引:0,他引:1
G E Tesar J F Rosenbaum M H Pollack M W Otto G S Sachs J B Herman L S Cohen S A Spier 《The Journal of clinical psychiatry》1991,52(2):69-76
To test the reported antipanic efficacy of clonazepam, the authors randomized 72 subjects with panic disorder to 6 weeks of treatment with either alprazolam, clonazepam, or placebo. Endpoint analysis demonstrated a significant beneficial effect of both active treatments, but not placebo treatment, on the frequency of panic attacks, overall phobia ratings, and the extent of disability. Comparison of the two active treatments revealed no significant differences and no consistent tendency for one agent to be favored over another, although power to detect small differences was limited. Sedation and ataxia were the most common side effects reported, but these effects were mild and transient and did not interfere with treatment outcome. The results of this double-blind, placebo-controlled trial are consistent with previous reports of clonazepam's antipanic efficacy. 相似文献
9.
The exact location of hemorrhage complicating anticoagulant therapy is sometimes difficult to establish. We present a case in which imaging with 99mTc-labeled red cells had a significant role in the diagnosis of soft-tissue bleeding in a paraplegic patient receiving long-term anticoagulation. 相似文献
10.
Sabrina Hundt Ulrike Haug Hermann Brenner 《Cancer epidemiology, biomarkers & prevention》2007,16(10):1935-1953
BACKGROUND: Despite different available methods for colorectal cancer (CRC) screening and their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to low compliance with screening. Minimally invasive tests based on the analysis of blood specimens may overcome this problem. The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics. METHOD: The PUBMED database was searched for relevant studies published until June 2006. Only studies with more than 20 cases and more than 20 controls were included. Information on the markers under study, on the underlying study populations, and on performance characteristics was extracted. Special attention was given to performance characteristics by tumor stage. RESULTS: Overall, 93 studies evaluating 70 different markers were included. Most studies were done on protein markers, but DNA markers and RNA markers were also investigated. Performance characteristics varied widely between different markers, but also between different studies using the same marker. Promising results were reported for some novel assays, e.g., assays based on SELDI-TOF MS or MALDI-TOF MS, for some proteins (e.g., soluble CD26 and bone sialoprotein) and also for some genetic assays (e.g., L6 mRNA), but evidence thus far is restricted to single studies with limited sample size and without further external validation. CONCLUSIONS: Larger prospective studies using study populations representing a screening population are needed to verify promising results. In addition, future studies should pay increased attention to the potential of detecting precursor lesions. 相似文献